ProfileGDS4718 / 244840_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 48% 49% 40% 47% 43% 34% 37% 43% 46% 46% 44% 40% 38% 39% 40% 47% 44% 41% 38% 50% 45% 38% 44% 41% 42% 39% 42% 38% 46% 37% 38% 33% 47% 43% 43% 33% 39% 42% 41% 39% 38% 40% 45% 36% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4116848
GSM549102patient 115, normal, homogenized [OPG study]5.4678949
GSM549104patient 119, normal, homogenized [OPG study]5.0047940
GSM549108patient 138, normal, homogenized [OPG study]5.3971647
GSM549119patient 077, normal, homogenized [OPG study]5.1434443
GSM549133patient 032, cancer, homogenized [OPG study]4.6583234
GSM549139patient 042, cancer, homogenized [OPG study]4.8360937
GSM549099patient 107, normal, homogenized [OPG study]5.1406843
GSM549109patient 139, normal, homogenized [OPG study]5.3414946
GSM549110patient 046, normal, homogenized [OPG study]5.2932746
GSM549114patient 063, normal, homogenized [OPG study]5.1678944
GSM549122patient 082, normal, homogenized [OPG study]5.0060840
GSM549134patient 033, cancer, homogenized [OPG study]4.8861538
GSM549136patient 036, cancer, homogenized [OPG study]4.8850739
GSM549140patient 044, cancer, homogenized [OPG study]4.9442540
GSM549111patient 047, normal, homogenized [OPG study]5.3216547
GSM549113patient 057, normal, homogenized [OPG study]5.1102144
GSM549132patient 031, cancer, homogenized [OPG study]4.9995441
GSM549137patient 038, cancer, homogenized [OPG study]4.869738
GSM549142patient 047, cancer, homogenized [OPG study]5.6654550
GSM549100patient 110, normal, homogenized [OPG study]5.2463445
GSM549107patient 135, normal, homogenized [OPG study]4.8587138
GSM549115patient 068, normal, homogenized [OPG study]5.1355344
GSM549116patient 072, normal, homogenized [OPG study]5.0088941
GSM549120patient 078, normal, homogenized [OPG study]5.0819742
GSM549131patient 030, cancer, homogenized [OPG study]4.9047739
GSM549118patient 074, normal, homogenized [OPG study]5.0729242
GSM549129patient 027, cancer, homogenized [OPG study]4.8988838
GSM549123patient 088, normal, homogenized [OPG study]5.2572346
GSM549124patient 006, cancer, homogenized [OPG study]4.904137
GSM549126patient 015, cancer, homogenized [OPG study]4.8837938
GSM549128patient 025, cancer, homogenized [OPG study]4.635433
GSM549103patient 117, normal, homogenized [OPG study]5.3813547
GSM549117patient 073, normal, homogenized [OPG study]5.0887843
GSM549138patient 041, cancer, homogenized [OPG study]5.1011843
GSM549141patient 045, cancer, homogenized [OPG study]4.6270233
GSM549130patient 028, cancer, homogenized [OPG study]4.9363739
GSM549101patient 111, normal, homogenized [OPG study]5.1448942
GSM549105patient 128, normal, homogenized [OPG study]5.0662541
GSM549106patient 134, normal, homogenized [OPG study]4.8873539
GSM549112patient 048, normal, homogenized [OPG study]4.8892838
GSM549125patient 011, cancer, homogenized [OPG study]4.982840
GSM549127patient 024, cancer, homogenized [OPG study]5.2390745
GSM549135patient 035, cancer, homogenized [OPG study]4.7402236